Marché des dispositifs de biopsie – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPHE100001402
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 196
Buy Now

Le marché des dispositifs de biopsie devrait atteindre 3 584,20 millions de dollars américains d'ici 2027, contre 2 230,86 millions de dollars américains en 2019. Le marché devrait croître à un TCAC de 6,2 % de 2020 à 2027.



A la biopsie est un examen médical généralement mis en œuvre par des chirurgiens, des radiologues interventionnels ou des cardiologues interventionnels pour prélever des échantillons de cellules ou de tissus ; ces examens aident à l'identification et à la détermination des états pathologiques. Le tissu est généralement observé au microscope par des pathologistes et peut également être examiné chimiquement. Les biopsies sont le plus souvent effectuées pour identifier les affections cancéreuses et inflammatoires.



Régions lucratives pour le marché des dispositifs de biopsie



Aperçu du marché



Augmentation des taux de cancer



La biopsie fait référence à un test diagnostique qui permet d'identifier divers types de cancer et d'anomalies non cancéreuses dans le corps humain. La prévalence croissante du cancer parmi la population est susceptible d'augmenter la croissance du marché des dispositifs de biopsie à travers le monde. Par exemple, au Canada, le cancer est la principale cause de décès dans la population, et il est considéré comme la deuxième cause après les maladies cardiaques aux États-Unis. Selon l'American Cancer Society, environ 1,9 million de nouveaux cas de cancer et 693 000 décès par cancer ont été enregistrés en 2018. Les cancers de la prostate sont les cancers les plus fréquemment diagnostiqués chez les hommes en Amérique du Nord ; cependant, les cancers du sein restent en tête chez les femmes. De plus, le cancer du poumon demeure la cause de décès la plus fréquente chez les deux sexes. On estime que le nombre de nouveaux cas d'incidence de cancer est de 439,2 pour 100 000 hommes et femmes par an.



Selon le profil national de santé, les cas de cancers courants, y compris les cancers du col de l'utérus, de la bouche et du sein , ont augmenté de 324 % en Inde de 2017 à 2018. De plus, le nombre total de patients se rendant dans les cliniques de maladies non transmissibles (MNT) a doublé entre 2017 et 2018, atteignant respectivement 35 millions et 66 millions. Le changement rapide du mode de vie et de la consommation d'alcool et de produits du tabac est l'un des principaux facteurs d'augmentation de l'incidence du cancer dans la population.



BD, Qiagen, F.Hoffmann La-Roche Ltd., Hologic et Boston Scientific Corporation font partie des principales entreprises fabriquant des dispositifs de biopsie et des accessoires pour diagnostiquer le cancer et d'autres maladies. Par conséquent, la prévalence croissante du cancer dans le monde devrait stimuler la croissance du marché mondial des dispositifs de biopsie au cours de la période de prévision.



Aperçu du marché basé sur les produits



Le marché des dispositifs de biopsie est segmenté sur la base du produit en biopsie à l'aiguille, plateaux de procédure, fils de localisation et autres. En 2019, le segment de la biopsie à l'aiguille représentait la plus grande part du marché mondial des dispositifs de biopsie. La croissance du marché pour ce segment est attribuée à l'adoption croissante des procédures de biopsie à l'aiguille en raison de leur grande précision, avec un minimum de blessures. En outre, le segment devrait également connaître le TCAC le plus rapide du marché au cours des années de prévision.



Marché mondial des dispositifs de biopsie, par produit - 2019 et 2027



Perspectives du marché basées sur la technologie



Basé sur la technologie, le marché mondial des dispositifs de biopsie est segmenté en tomodensitométrie, biopsie guidée par ultrasons, biopsie stéréotaxique, IRM et autres. En 2019, le segment de la biopsie guidée par échographie détenait la plus grande part de marché. Cependant, le segment de la tomodensitométrie devrait enregistrer un TCAC important au cours de la période de prévision.



Aperçu du marché basé sur les applications



Le marché mondial des dispositifs de biopsie, basé sur l'application, est segmenté dans la biopsie pulmonaire, la biopsie rénale, la biopsie hépatique, la biopsie mammaire et autres. En 2019, le segment de la biopsie mammaire détenait la plus grande part du marché, et il devrait également enregistrer le TCAC le plus élevé entre 2020 et 2027.



Perspectives stratégiques



Partenariats, lancements de produits , et les acquisitions sont les stratégies les plus couramment adoptées par les entreprises pour étendre leur présence dans le monde et répondre à la demande croissante en élargissant leurs portefeuilles de produits. Par exemple, en décembre 2017, BD, l'un des principaux fournisseurs de technologies médicales, a acquis CR Bard, Inc. Cette acquisition a créé un nouveau leader du secteur de la santé sur le marché mondial. Bard, avec son solide portefeuille de produits et son pipeline d'innovations, a élargi la portée des opportunités dans le secteur des dispositifs médicaux à croissance rapide sur les marchés mondiaux.



Marché mondial des dispositifs de biopsie - Par produit




  • Biopsie à l'aiguille

    • Dispositifs de biopsie de base

    • Aiguilles de biopsie par aspiration

    • Dispositifs de biopsie assistée par le vide (VAB)


    < /li>
  • Fils de localisation

  • Plateaux de procédure

  • Autres


Marché mondial des dispositifs de biopsie – Par technologie




  • CT-Scan

  • Biopsie guidée par échographie

  • Biopsie guidée par stéréotaxie

  • Biopsie guidée par IRM

  • Autres

Marché mondial des dispositifs de biopsie - Par application




  • Biopsie pulmonaire

  • Biopsie rénale

  • Biopsie hépatique

  • < li>Beast Biopsy
  • Autres


Marché des appareils de biopsie - Par géographie




  • Amérique du Nord

    • États-Unis
    • Canada

    • Mexique



  • Europe

    • France

    • Allemagne

    • < li>Italie
    • Royaume-Uni

    • Espagne

    • Suède

    • Danemark

    • Norvège


  • Asie-Pacifique

    • Chine

    • Inde

    • Corée du Sud

    • Japon

    • Australie



  • Moyen-Orient et Afrique

    • Afrique du Sud

    • Arabie saoudite

    • EAU


    • Amérique du Sud et centrale

      • Brésil

      • Argentine




    Profils d'entreprises< /h3>

    • BD

    • B. Braun Melsungen AG

    • Boston Scientific Corporation

    • Cardinal Health, Inc.

    • Cook Medical LLC

    • Danaher

    • Fujifilm Corporation

    • Hologic, Inc.

    • Medtronic

    • Dispositifs médicaux Argon


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is biopsy?

A biopsy is a medical examination generally implemented by a surgeon, interventional radiologist, or an interventional cardiologist to extract sample cells or tissues and helps in identification, existence of a disease. The tissue is generally observed under a microscope by a pathologist, and can also be examined chemically. Biopsies are most commonly performed to identify cancerous and inflammatory conditions.

What are the driving factors for the biopsy devices market across the globe?

The biopsy devices market is anticipated to grow with a significant rate in the coming years, owing to factors such as rising patient awareness on cancer and the improvement in biopsy procedures. Increasing incidences of cancer such as breast, prostate, & lung, and rapid technological advancements, initiatives to spread awareness about cancer are expected to offer growth opportunities for the players operating in the market.

What is the regional analysis in terms of biopsy devices market?

North America is the largest market for the biopsy devices market. The factors that are responsible for the dominance of the region include rising government support through the for cancer care in the US and Canada, rising incidence of cancer patients leading to increased demand in kits and products used for testing and diagnosis, increasing awareness among general populace regarding advantages of early testing of diseases and consistent development and launch of novel biopsy products in the market through advanced and extensive research and development. The biopsy devices market in the US is expected to be the largest in the North American region. The growth of the market in the country is attributed to the active participation and support of the government towards the cancer care. Besides this, the increase in the number of cancer population and the technological developments in biopsy devices are likely to help in the growth of the market.

The List of Companies - Biopsy Devices Market

  1. BD
  2. B. Braun Melsungen AG
  3. Boston Scientific Corporation
  4. Cardinal Health, Inc.
  5. Cook Medical LLC
  6. Danaher
  7. Fujifilm Corporation
  8. Hologic, Inc.
  9. Medtronic
  10. Argon Medical Devices

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports